• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medexus Pharmaceuticals Inc (TSX:MDP)

4.920 +0.070 (+1.44%)
Delayed Quote Updated: 4:00 PM EDT, Oct 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,470
Open 4.870
Bid (Size) 4.800 (4)
Ask (Size) 4.940 (20)
Prev. Close 4.850
Today's Range 4.870 - 4.920
52wk Range 2.510 - 5.500
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Medexus Pharmaceuticals Q1 Earnings Call Highlights ↗
August 11, 2026
Medexus Pharmaceuticals (TSE:MDP) reported higher first-quarter fiscal 2027 revenue and adjusted EBITDA, supported by continued growth for GRAFAPEX and a stronger contribution from IXINITY, while... 
Via MarketBeat
Topics Earnings
News headline image
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 18, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire

Performance

52-Week Range 10.5% below 52-week high
4.920
2.5152W Low 5.5052W High
1 Week 0.8% below 1-week high
4.691W Low 4.961W High

Medexus Pharmaceuticals Inc (MDP) traded between $2.51 and $5.50 over the past 52 weeks and last traded at $4.92, 10.5% below its 52-week high. Over the past week it ranged between $4.69 and $4.96.

Past 12 Months
+2.1%
-3.3%
-3.1%
+23.6%
+59.2%
+70.8%
1W +$0.10
1M -$0.17
3M -$0.16
6M +$0.94
YTD +$1.83
1Y +$2.04

MDP was +70.8% over the past year, +23.6% over six months, +59.2% year to date, +2.1% in the last week.

12 Months vs Market
MDP
+70.8%
DIA
+12.3%
SPY
+14.6%
QQQ
+17.3%
IWM
+11.1%

Over the past 12 months MDP returned +70.8% versus DIA (Dow) +12.3%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.3% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 0.36× 3-mo avg
Today 14,470 3-mo avg 40.7K
1W
31.1K
1M
33.7K
3M
40.7K
6M
41.5K
YTD
44.6K
1Y
44.4K

MDP most recently traded 14,470 shares against a 3-month average daily volume of 40.7K.

More News

Read More
News headline image
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
April 11, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Earnings Scheduled For October 28, 2021 ↗
October 28, 2021
Via Benzinga
News headline image
Medexus Announces New License Deal for Topical Terbinafine
March 22, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Announces US$58.5 million in New Credit Facilities
March 08, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Pharmaceuticals Inc. (TSX: MDP) (OTCQX: MEDXF) Featured in Coverage of the 35th Annual Roth Conference
March 06, 2023
Via Investor Brand Network
News headline image
Medexus to Participate in 35th Annual Roth Conference
March 06, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
February 08, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Welcomes Two New Board Members
February 06, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
February 01, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
January 31, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
January 12, 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
November 08, 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Schedules Second Quarter 2023 Conference Call
November 02, 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023
October 06, 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
Medexus and MidCap Agree to Increase in MidCap’s Revolving Loan Commitment Amount
September 29, 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
News headline image
How To Pick Dividend-Payers, Plus My Favorite One To Buy Now ↗
April 18, 2022
Via Talk Markets
News headline image
Fitness App Hopes to Innovate, Keep Resolutions, by Paying To Complete a Workout Built for Your Level of Exercise ↗
January 04, 2022
Via Benzinga
News headline image
Sidoti December Micro Cap Virtual Conference
December 07, 2021
From Sidoti & Company, LLC
Via AccessWire
News headline image
The Rise And Fall Of MySpace ↗
November 14, 2021
Via Talk Markets
News headline image
Paul Rudd Named People's Sexiest Man Alive For 2021 ↗
November 10, 2021
Via Benzinga
News headline image
Making a Difference When You Invest? Medexus Says It Improves Lives ↗
November 10, 2021
Via Benzinga
News headline image
What Is IAC Planning With Its Acquisition of Magazine Publisher Meredith? ↗
October 20, 2021
Via The Motley Fool
InvestorNewsBreaks – Nexstar Media Group Inc.’s (NASDAQ: NXST) Hartford-Based Station to Launch NEXTGEN TV
October 12, 2021
Via Investor Brand Network

Frequently Asked Questions

Is Medexus Pharmaceuticals Inc publicly traded?
Yes, Medexus Pharmaceuticals Inc is publicly traded.
What exchange does Medexus Pharmaceuticals Inc trade on?
Medexus Pharmaceuticals Inc trades on the Toronto Stock Exchange
What is the ticker symbol for Medexus Pharmaceuticals Inc?
The ticker symbol for Medexus Pharmaceuticals Inc is MDP on the Toronto Stock Exchange
What is the current price of Medexus Pharmaceuticals Inc?
The current price of Medexus Pharmaceuticals Inc is 4.920
When was Medexus Pharmaceuticals Inc last traded?
The last trade of Medexus Pharmaceuticals Inc was at 10/20/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap